Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings

Driehaus Capital Management added 432,510 shares of PRAX in the fourth quarter; the estimated value of the transaction was $80.54 million. Meanwhile, the quarter-end position value rose by $248.48 million, reflecting both share purchases and stock price movement.